Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
We evaluate ETFs that minimize taxes on retirement income, aiming to boost net returns while controlling tax impact on withdrawals.
23,314 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Artificial intelligence isn’t just software. It’s a hardware race that powers every smart AI system. This tech stock ...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...
When the government backs quantum startups with significant funding, investors wonder which stocks stand to gain. Thi...
IBM argues that data gravity keeps information in place. This investing piece explains why that matters, how AI reinf...
New home sales are falling again, and the trade labor shortage continues to shape lending and construction decisions....
Investors chase the next big energy winner as AI drives data centers demand. Oklo presents a high-risk, high-puture o...
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...
Across major firms, AI agents now outnumber human staff in many back offices and customer channels. Leaders outline g...
Is netflix stock cheap overvalued? This article dives into how to gauge Netflix's value using real-world metrics, sce...
When the Federal Reserve keeps rates unchanged, big retailers can swing on a dime. This article dives into why home d...
Binance founder Changpeng Zhao described Hyperliquid’s no-KYC model as “awesome,” while signaling Binance would not a...